Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Raras (34)

2024

  1. Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

    Science translational medicine, Vol. 16, Núm. 734, pp. eadg7962

2023

  1. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis

    CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320

  2. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  3. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

    British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294

  4. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

    Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222

2022

  1. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Blood, Vol. 140, Núm. 1, pp. 38-44

  2. CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival

    Cancers, Vol. 14, Núm. 2

  3. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia

    Molecular Oncology, Vol. 16, Núm. 16, pp. 2899-2919

2021

  1. A clinico-pathological and molecular analysis reveals differences between solitary (early and late-onset) and synchronous rectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  2. Pathogenic convergence of CNVs in genes functionally associated to a severe neuromotor developmental delay syndrome

    Human Genomics, Vol. 15, Núm. 1

2020

  1. Helpful criteria when implementing ngs panels in childhood lymphoblastic leukemia

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-15

  2. Novel dominant kcnq2 exon 7 partial in-frame duplication in a complex epileptic and neurodevelopmental delay syndrome

    International Journal of Molecular Sciences, Vol. 21, Núm. 12, pp. 1-11

  3. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4

    Cells, Vol. 9, Núm. 4

  4. Prognostic gene expression signature for high-grade serous ovarian cancer

    Annals of Oncology, Vol. 31, Núm. 9, pp. 1240-1250

2019

  1. Association of polyps with early-onset colorectal cancer and throughout surveillance: novel clinical and molecular implications

    Cancers, Vol. 11, Núm. 12

2018

  1. Human endoglin as a potential new partner involved in platelet–endothelium interactions

    Cellular and Molecular Life Sciences, Vol. 75, Núm. 7, pp. 1269-1284

  2. Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome

    British Journal of Dermatology, Vol. 178, Núm. 1, pp. 198-206

2017

  1. Serous tubal intraepithelial carcinomas associated with high-grade serous ovarian carcinomas: a systematic review

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 124, Núm. 6, pp. 872-878

  2. The role of endoglin in post-ischemic revascularization

    Angiogenesis, Vol. 20, Núm. 1

2016

  1. Endoglin regulates mural cell adhesion in the circulatory system

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 8, pp. 1715-1739